Physiological role of mucins in the colonic barrier integrity;Rôles physiologiques des mucines dans la barrière colique

Gastroenterologie Clinique et Biologique

Volumn 30, Issue 8-9, 2006, Pages 965-974

  Gaudier, Estelle ^a   Hoebler, Christine ^a,b  

^a Universite de Nantes   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; MUCIN 1; MUCIN 11; MUCIN 17; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 6; UNCLASSIFIED DRUG;

CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; COLON MUCOSA; HUMAN; IMMUNOMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 33750684996     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0399-8320(06)73358-9     Document Type: Review

References (111)

1. Porchet N, Aubert JP. MUC genes: mucin or not mucin? That is the question. Med Sci (Paris) 2004;20:569-74.
2. Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 2004;23:77-99.
3. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, Porchet N, et al. Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 2001;49:544-51.
4. Lidell ME, Johansson ME, Hansson GC. An autocatalytic cleavage in the C terminus of the human MUC2 mucin occurs at the low pH of the late secretory pathway. J Biol Chem 2003;278:13944-51.
5. Thornton DJ, Davies JR, Kraayenbrink M, Richardson PS, Sheehan JK, Carlstedt I. Mucus glycoproteins from "normal" human tracheobronchial secretion. Biochem J 1990;265:179-86.
6. Thornton DJ, Sheehan JK, Lindgren H, Carlstedt I. Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural "architecture". Biochem J 1991;276 (Pt 3):667-75.
7. Bramwell ME, Wiseman G, Shotton DM. Electron-microscopic studies of the CA antigen, epitectin. J Cell Sci 1986;86:249-61.
8. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 2002;109:883-93.
9. Shirazi T, Longman RJ, Corfield AP, Probert CS. Mucins and inflammatory bowel disease. Postgrad Med J 2000;76:473-8.
10. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002;32:519-27.
11. Hoffmann W, Jagla W. Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 2002;213:147-81.
12. Szentkuti L. Light observations on luminally adminstrated dyes, dextrans, nanospheres and microsperes in the pre-epithelial mucus gel layer of the rat distal colon. J Controlled Release 1997;46:233-42.
13. Iiboshi Y, Nezu R, Cui L, Chen K, Khan J, Yoshida H, et al. Adhesive mucous gel layer and mucus release as intestinal barrier in rats. JPEN J Parenter Enteral Nutr 1996;20:98-104.
14. Khan J, Iiboshi Y, Cui L, Wasa M, Okada A. Role of intestinal mucus on the uptake of latex beads by Peyer's patches and on their transport to mesenteric lymph nodes in rats. JPEN J Parenter Enteral Nutr 1999;23:19-23.
15. Chapoy P. Mucus et écosystème intestinal en situation normale et pathologique. In: Bara J, Christen Y, Droy-Lefaix MT, eds. Digestive Mucus - from research to application. IRVINN éditions Neuilly-sur-Seine, 2000: 69-75.
16. Lugea A, Salas A, Casalot J, Guarner F, Malagelada JR. Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins. Gut 2000;46:515-21.
17. Robbe C, Capon C, Maes E, Rousset M, Zweibaum A, Zanetta JP, et al. Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract. J Biol Chem 2003;278:46337-48.
18. Robbe C, Capon C, Coddeville B, Michalski JC. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 2004;384:307-16.
19. Matsumura A, Saito T, Arakuni M, Kitazawa H, Kawai Y, Itoh T. New binding assay and preparative trial of cell-surface lectin from Lactobacillus acidophilus group lactic acid bacteria. J Dairy Sci 1999;82:2525-9.
20. Paerregaard A, Espersen F, Jensen OM, Skurnik M. Interactions between Yersinia enterocolitica and rabbit ileal mucus: growth, adhesion, penetration, and subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun 1991;59:253-60.
21. Sudha PS, Devaraj H, Devaraj N. Adherence of Shigella dysenteriae 1 to human colonic mucin. Curr Microbiol 2001;42:381-7.
22. Gork AS, Usui N, Ceriati E, Drongowski RA, Epstein MD, Coran AG, et al. The effect of mucin on bacterial translocation in I-407 fetal and Caco-2 adult enterocyte cultured cell lines. Pediatr Surg Int 1999;15:155-9.
23. Mattar AF, Teitelbaum DH, Drongowski RA, Yongyi F, Harmon CM, Coran AG. Probiotics up-regulate MUC-2 mucin gene expression in a Caco-2 cell-culture model. Pediatr Surg Int 2002;18:586-90.
24. Usui N, Ray CJ, Drongowski RA, Coran AG, Harmon CM. The effect of phospholipids and mucin on bacterial internalization in an enterocyte-cell culture model. Pediatr Surg Int 1999;15:150-4.
25. Nutten S, Sansonetti P, Huet G, Bourdon-Bisiaux C, Meresse B, Colombel JF, et al. Epithelial inflammation response induced by Shigella flexneri depends on mucin gene expression. Microbes Infect 2002;4:1121-4.
26. Matsuo K, Ota H, Akamatsu T, Sugiyama A, Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 1997;40:782-9.
27. Sakamoto K, Mori Y, Takagi H, Iwata H, Yamada T, Futamura N, et al. Translocation of Salmonella typhimurium in rats on total parenteral nutrition correlates with changes in intestinal morphology and mucus gel. Nutrition 2004;20:372-6.
28. Maxson RT, Dunlap JP, Tryka F, Jackson RJ, Smith SD. The role of the mucus gel layer in intestinal bacterial translocation. J Surg Res 1994;57:682-6.
29. Moncada D, Keller K, Chadee K. Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function. Infect Immun 2003;71:838-44.
30. Leiper K, Campbell BJ, Jenkinson MD, Milton J, Yu LG, Democratis J, et al. Interaction between bacterial peptides, neutrophils and goblet cells: a possible mechanism for neutrophil recruitment and goblet cell depletion in colitis. Clin Sci (Lond) 2001;101:395-402.
31. Coconnier MH, Dlissi E, Robard M, Laboisse CL, Gaillard JL, Servin AL. Listeria monocytogenes stimulates mucus exocytosis in cultured human polarized mucosecreting intestinal cells through action of listeriolysin O. Infect Immun 1998;66:3673-81.
32. Lievin-Le Moal V, Huet G, Aubert JP, Bara J, Forgue-Lafitte ME, Servin AL, et al. Activation of mucin exocytosis and upregulation of MUC genes in polarized human intestinal mucin-secreting cells by the thiol-activated exotoxin listeriolysin O. Cell Microbiol 2002;4:515-29.
33. Smirnova MG, Guo L, Birchall JP, Pearson JP. LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells. Cell Immunol 2003;221:42-9.
34. Jarry A, Merlin D, Velcich A, Hopfer U, Augenlicht LH, Laboisse CL. Interferon-gamma modulates cAMP-induced mucin exocytosis without affecting mucin gene expression in a human colonic goblet cell line. Eur J Pharmacol 1994;267:95-103.
35. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999;276:G941-G950.
36. Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003;52:827-33.
37. Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004;286:G613-G626.
38. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S, et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002;295:1726-9.
39. Buisine MP, Colombel JF, Lecomte-Houcke M, Gower P, Aubert JP, Porchet N, et al. Abnormal mucus in cap polyposis. Gut 1998;42:135-8.
40. Buisine MP, Devisme L, Degand P, Dieu MC, Gosselin B, Copin MC, et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 2000;48:1667-76.
41. Porchet N, Buisine MP, Desseyn JL, Moniaux N, Nollet S, Degand P, et al. MUC genes: a superfamily of genes? Towards a functional classification of human apomucins. J Soc Biol 1999;193:85-99.
42. Meindl A, Berger W, Meitinger T, van de PD, Achatz H, Dorner C, et al. Norrie disease is caused by mutations in an extracellular protein resembling C-terminal globular domain of mucins. Nat Genet 1992;2:139-43.
43. Sun PD, Davies DR. The cystine-knot growth-factor superfamily. Annu Rev Biophys Biomol Struct 1995;24:269-91.
44. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800.
45. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, Remaut E, et al. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 2004;127:502-13.
46. Renes IB, Verburg M, Van Nispen DJ, Taminiau JA, Buller HA, Dekker J, et al. Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int J Colorectal Dis 2002;17:317-26.
47. Itoh H, Beck PL, Inoue N, Xavier R, Podolsky DK. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest 1999;104:1539-47.
48. Matsuoka Y, Pascall JC, Brown KD. Quantitative analysis reveals differential expression of mucin (MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine. Biochim Biophys Acta 1999;1489:336-44.
49. Sternberg LR, Byrd JC, Yunker CK, Dudas S, Hoon VK, Bresalier RS. Liver colonization by human colon cancer cells is reduced by anti-sense inhibition of MUC2 mucin synthesis. Gastroenterology 1999;116:363-71.
50. Corfield AP, Myerscough N, Longman R, Sylvester P, Arul S, Pignatelli M. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut 2000;47:589-94.
51. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82-5.
52. Bara J, Forgue-Laffite ME, Buisine MP. Expression of gastric MUC5AC mucin during colon carcinogenesis. In: Handbook of immunohistochemistry and in situ hybridization of human carcinomas. Hayat MA, SanDiego: Elsevier Academic Press 2004:167-82.
53. Buisine MP, Janin A, Maunoury V, Audie JP, Delescaut MP, Copin MC, et al. Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 1996;110:84-91.
54. Buisine MP, Devisme L, Savidge TC, Gespach C, Gosselin B, Porchet N, et al. Mucin gene expression in human embryonic and fetal intestine. Gut 1998;43:519-24.
55. Agrawal B, Gendler SJ, Longenecker BM. The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy. Mol Med Today 1998;4:397-403.
56. Fung PY, Longenecker BM. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA). Cancer Res 1991;51:1170-6.
57. Zhang K, Baeckstrom D, Brevinge H, Hansson GC. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 1996;60:538-49.
58. Kim JA, Dayton MA, Aldrich W, Triozzi PL. Modulation of CD4 cell cytokine production by colon cancer-associated mucin. Cancer Immunol Immunother 1999;48:525-32.
59. Hey NA, Graham RA, Seif MW, Aplin JD. The polymorphic epithelial mucin MUC1 in human endometrium is regulated with maximal expression in the implantation phase. J Clin Endocrinol Metab 1994;78:337-42.
60. Zrihan-Licht S, Baruch A, Elroy-Stein O, Keydar I, Wreschner DH. Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules. FEBS Lett 1994;356:130-6.
61. Wen Y, Caffrey TC, Wheelock MJ, Johnson KR, Hollingsworth MA. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J Biol Chem 2003;278:38029-39.
62. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J Biol Chem 1997;272:12492-4.
63. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004;4:45-60.
64. Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J Biol Chem 2001;276:13057-64.
65. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J Biol Chem 2001;276:6061-4.
66. Denker BM, Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol 1998;274:F1-F9.
67. Meerzaman D, Shapiro PS, Kim KC. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. Am J Physiol Lung Cell Mol Physiol 2001;281:L86-L91.
68. Parmley RR, Gendler SJ. Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus. J Clin Invest 1998;102:1798-806.
69. Hinojosa-Kurtzberg AM, Johansson ME, Madsen CS, Hansson GC, Gendler SJ. Novel MUC1 splice variants contribute to mucin overexpression in CFTR-deficient mice. Am J Physiol Gastrointest Liver Physiol 2003;284:G853-G862.
70. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995;129:255-65.
71. Wesseling J, van der Valk SW, Hilkens J. A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1. Mol Biol Cell 1996;7:565-77.
72. Regimbald LH, Pilarski LM, Longenecker BM, Reddish MA, Zimmermann G, Hugh JC. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res 1996;56:4244-9.
73. Zhang K, Baeckstrom D, Brevinge H, Hansson GC. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion. Tumour Biol 1997;18:175-87.
74. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ. Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 1995;270:30093-101.
75. Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T. MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 1994;106:353-61.
76. Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K, et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004;10:2790-6.
77. Jang KT, Chae SW, Sohn JH, Park HR, Shin HS. Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas. J Korean Med Sci 2002;17:29-33.
78. Nakagawa K, Akagi J, Takai E, Tamori Y, Okino T, Kako H, et al. Prognostic values of MUC-1 molecule expressing cytokine receptor-like epitope and DF3 in patients with gastric carcinoma. Int J Oncol 1999;14:425-35.
79. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA. Cell signaling through membrane mucins. Bioessays 2003;25:66-71.
80. Hollingsworth MA, Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004;4:45-60.
81. Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 2002;71:149-85.
82. Ramsauer VP, Carraway CA, Salas PJ, Carraway KL. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. J Biol Chem 2003;278:30142-7.
83. Jepson S, Komatsu M, Haq B, Arango ME, Huang D, Carraway CA, et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27(kip), but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways. Oncogene 2002;21:7524-32.
84. Wreschner DH, McGuckin MA, Williams SJ, Baruch A, Yoeli M, Ziv R, et al. Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins. Protein Sci 2002;11:698-706.
85. Dekker J, Rossen JW, Buller HA, Einerhand AW. The MUC family: an obituary. Trends Biochem Sci 2002;27:126-31.
86. Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N, et al. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis 1999;5:24-32.
87. Blank M, Klussmann E, Kruger-Krasagakes S, Schmitt-Graff A, Stolte M, Bornhoeft G, et al. Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 1994;59:301-6.
88. Gratchev A, Bohm C, Riede E, Foss HD, Hummel M, Mann B, et al. Regulation of mucin MUC2 gene expression during colon carcinogenesis. Ann N Y Acad Sci 1998;859:180-3.
89. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53:641-51.
90. Ogata S, Uehara H, Chen A, Itzkowitz SH. Mucin gene expression in colonic tissues and cell lines. Cancer Res 1992;52:5971-8.
91. Sylvester PA, Myerscough N, Warren BF, Carlstedt I, Corfield AP, Durdey P, et al. Differential expression of the chromosome 11 mucin genes in colorectal cancer. J Pathol 2001;195:327-35.
92. Tytgat KM, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem Biophys Res Commun 1996;224:397-405.
93. Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing PX, Karsten U. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J Histochem Cytochem 1997;45:1547-57.
94. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59:4083-9.
95. Williams SJ, Wreschner DH, Tran M, Eyre HJ, Sutherland GR, McGuckin MA. Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 2001;276:18327-36.
96. Van Klinken BJ, van der Wal JW, Einerhand AW, Buller HA, Dekker J. Sulphation and secretion of the predominant secretory human colonic mucin MUC2 in ulcerative colitis. Gut 1999;44:387-93.
97. Ajioka Y, Allison LJ, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol 1996;49:560-4.
98. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA, et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 2000;6:1909-16.
99. Manne U, Weiss HL, Grizzle WE. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res 2000;6:4017-25.
100. Matsuda K, Masaki T, Watanabe T, Kitayama J, Nagawa H, Muto T, et al. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma. Jpn J Clin Oncol 2000;30:89-94.
101. Campbell BJ, Finnie IA, Hounsell EF, Rhodes JM. Direct demonstration of increased expression of Thomsen-Friedenreich (TF) antigen in colonic adenocarcinoma and ulcerative colitis mucin and its concealment in normal mucin. J Clin Invest 1995;95:571-6.
102. Hanisch FG.O-glycosylation of the mucin type. Biol Chem 2001;382:143-9.
103. Hara A, Saegusa M, Mitomi H, Kurihara M, Ishihara K, Hotta K, et al. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities. Pathol Res Pract 2000;196:159-66.
104. Corfield AP, Myerscough N, Bradfield N, Corfield CA, Gough M, Clamp JR, et al. Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J 1996;13:809-22.
105. Jass JR, Roberton AM. Colorectal mucin histochemistry in health and disease: a critical review. Pathol Int 1994;44:487-504.
106. Parker N, Tsai HH, Ryder SD, Raouf AH, Rhodes JM. Increased rate of sialylation of colonic mucin by cultured ulcerative colitis mucosal explants. Digestion 1995;56:52-6.
107. Pullan RD, Thomas GA, Rhodes M, Newcombe RG, Williams GT, Allen A, et al. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 1994;35:353-9.
108. Raouf AH, Tsai HH, Parker N, Hoffman J, Walker RJ, Rhodes JM. Sulphation of colonic and rectal mucin in inflammatory bowel disease: reduced sulphation of rectal mucus in ulcerative colitis. Clin Sci (Lond) 1992;83:623-6.
109. Rhodes JM.Mucins and inflammatory bowel disease. QJM 1997;90:79-82.
110. Probert CS, Warren BF, Perry T, Mackay EH, Mayberry JF, Corfield AP. South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut 1995;36:696-702.
111. Bresalier RS, Ho SB, Schoeppner HL, Kim YS, Sleisenger MH, Brodt P, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996;110:1354-67.